Migraine Treatment of the Month: Qulipta Re-Visited
/
As we have discussed many times before in Migraineur, “migraine” is the constellation of symptoms that result from…
Read More
Latest News
Migraine Treatment of the Month: The best oral preventive medicine for migraine that you’ve probably never heard of: Zonisamide
/
There are a myriad of therapies widely used for migraine prevention. A few are both FDA-approved and possessed of a solid scientific evidence…
Read MoreMigraine Treatment of the Month: A Vyepti “Real World” Update
/
Epitenzumab (Vyepti) was highlighted in this magazine as a “migraine treatment of the month” in the Fall 2022 issue…
Read MoreMigraine Treatments of the Month: The Oral Triptans
/
Ever since injectable sumatriptan was approved for use in the US…
Read MoreMigraine Treatments of the Month: Topiramate
/
Examined through the lens of the historical development of therapies for migraine, topiramate is a particularly interesting drug...
Read MoreMigraine Treatments of the Month: Zavzpret Nasal Spray
/
Ever since injectable sumatriptan was approved for use in the US…
Read MoreMigraine Treatments of the Month: The Anti-CGRP Monoclonal Antibodies
/
Each of the mABs is effective in a high percentage of patients...
Read MoreMigraine Treatments of the Month: A root, a spray and an intravenous infusion: 3 different approaches to migraine relief
/
Butterbur (scientific name Petasites hybridus) is a member of the sunflower family that grows in marshes and is largely found in southern Europe and parts of Asia…
Read MoreMigraine Treatment of the Month: Divalproex sodium: an oldie... but a goodie?
/
In 1978 valproic acid (also known as sodium valproate or divalproex sodium) was approved by the FDA for seizure prevention…
Read MoreMigraine Treatment of the Month: Atogepant (Qulipta)
/
The nervous system is a complex collection of interactive electronic circuits that conduct…
Migraine Treatment of the Month: BotoxA
/
Although onabotulinumtoxinA (BotoxA) has been FDA-approved for the treatment of chronic migraine for well over 10 years…
Read MoreMigraine Treatment of the Month: Reyvow (lasmiditan)
/
Within the past two years 3 new oral medications intended for treatment of acute migraine headache…
Read MoreMigraine Treatments of the Month: Humble but Mighty Indomethacin
/
Indomethacin is hardly a newcomer to medical therapeutics. This nonsteroidal anti-inflammatory drug (NSAID) initially became available for general clinical use in 1963…
Read MoreMigraine Treatments of the Month: The Need for Speed
/
For this issue I decided to exercise some editorial prerogative and up the ante to feature two treatments of the month instead of the usual one.
Read More
Vestibular Migraine: Where Headache and Dizziness Intersect
/
Learn how migraine and “dizziness” may be clinically and biologically linked.
Read MoreMigraine Treatment of the Month, Nurtec ODT: Standing Out from the Crowd
/
Since May 2018, within a period of just under two years, seven new medications for migraine treatment have received FDA approval and are available for routine clinical use. Our “Migraine Treatment of the Month” features the newest of the seven: rimegepant (Nurtec ODT; Biohaven Pharmaceuticals).
Read MoreHeadache History Questionnaire for Patients
/
Download and complete this headache questionnaire prior to visiting your doctor if you want to get the most out of your visit.
Read MoreMigraine Treatment of the Month
/
With so many new therapies for migraine rapidly becoming available, it was difficult to pick one single therapy to highlight in this issue.
Read MoreMigraine Treatment of the Month: Tosymra
/
Ever since injectable sumatriptan was released (as Imitrex) for general clinical use in 1992, investigators have searched for a needle-less alternative for delivery of a triptan or triptan-like medication which would offer the same level of effectiveness, the same rapidity of effectiveness and the advantage of avoiding the oral route of administration in migraineurs experiencing nausea and vomiting with their headaches.
Read More
